Intrinsiqq
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. Insider Trading

BNTC

⊜ Compare
Last 12 months

Insiders bought $1.9M on the open market and sold nothing.

Net open-market
+$1.9M
1 buy · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Dec 2025
Dec 29, 2025

Get an email when BNTC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Dec 23, 2025 – Dec 29, 2025
    Aaron Cowen
    Director · bought 144,223 at avg $13.20
    $1.9M
    8.5% of stake
  • Dec 18, 2025 – Dec 22, 2025
    Averill Madison Master Fund, Ltd.
    Large holder · bought 46,141 at avg $11.68
    539K
    2.6% of stake
  • Nov 7, 2025
    Suvretta Capital Management, LLC
    Large holder · bought 1,481,481 at avg $13.50
    $20M
    438% of stake
  • Mar 31, 2025
    Suvretta Capital Management, LLC
    Large holder · bought 16,497 at avg $12.83
    212K
    1.6% of stake
  • Mar 26, 2025
    Aaron Cowen
    Large holder · bought 900,000 at avg $13.00
    $11.7M
    540% of stake
  • Dec 23, 2024 – Dec 24, 2024
    Aaron Cowen
    Large holder · bought 47,520 at avg $11.09
    527K
    5.2% of stake
  • Dec 3, 2024
    Suvretta Capital Management, LLC
    Large holder · bought 42,000 at avg $9.60
    403K
    4.6% of stake
  • Nov 19, 2024 – Nov 20, 2024
    Averill Master Fund, Ltd.
    Large holder · bought 41,436 at avg $10.05
    417K
    4.6% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BNTC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BNTC

CompareIntrinsic value
IXHLIncannex Healthcare Inc.
$2.52-2.33%10
ATNMActinium Pharmaceuticals Inc.
$1.48-3.27%30
AVTXAvalo Therapeutics Inc.
$7.17-3.63%10
AXIMAxim Biotechnologies Inc.
$0.00+0.00%0
SILOSilo Pharma Inc.
$1.23-1.60%10
OWPCOne World Products Inc.
$0.00+0.00%46
IBIOiBio, Inc.
$0.77-4.94%10
ALTAltimmune, Inc.
$2.04-4.67%10

Held by ETFs

BNTC is in 4 US ETFs. The largest of them, with BNTC's weight in each:

Spot a number that looks wrong? Check it in BNTC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BNTC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.